Foldax Inc.

Foldax Inc. is a clinical-stage medical device company based in Salt Lake City, Utah. The company focuses on developing next-generation synthetic polymer heart valves, utilizing its proprietary material, LifePolymer™. This non-animal-based polymer is designed for heart valve applications, offering biocompatibility and resistance to calcification, which enhances durability compared to traditional valves. The flagship products of Foldax are the TRIA™ aortic and mitral heart valves. These valves are the first of their kind made from synthetic polymer, aimed at improving hemodynamic performance and longevity while addressing sourcing issues related to animal-derived valves. Foldax employs advanced robotic automation in its manufacturing process, ensuring precision and scalability while reducing costs. Foldax's mission is to provide durable and accessible heart valve solutions for diverse patient populations worldwide, including those with rheumatic valve disease in developing countries and older patients in developed nations. The company combines expertise in polymer science and heart valve design to meet the growing global demand for innovative heart valve therapies.

• Employees41
• Founded2014
• Annual Revenue$4000000
• Total Funding$34025000